CNTB
Price
$1.17
Change
+$0.09 (+8.33%)
Updated
Jul 3 closing price
Capitalization
64.97M
VERA
Price
$24.00
Change
+$0.35 (+1.48%)
Updated
Jul 3 closing price
Capitalization
1.53B
33 days until earnings call
Interact to see
Advertisement

CNTB vs VERA

Header iconCNTB vs VERA Comparison
Open Charts CNTB vs VERABanner chart's image
Connect Biopharma Holdings
Price$1.17
Change+$0.09 (+8.33%)
Volume$148.66K
Capitalization64.97M
Vera Therapeutics
Price$24.00
Change+$0.35 (+1.48%)
Volume$629.76K
Capitalization1.53B
CNTB vs VERA Comparison Chart in %
Loading...
CNTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTB vs. VERA commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTB is a Buy and VERA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CNTB: $1.17 vs. VERA: $24.00)
Brand notoriety: CNTB and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTB: 176% vs. VERA: 31%
Market capitalization -- CNTB: $64.97M vs. VERA: $1.53B
CNTB [@Biotechnology] is valued at $64.97M. VERA’s [@Biotechnology] market capitalization is $1.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTB’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • CNTB’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTB is a better buy in the long-term than VERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTB’s TA Score shows that 4 TA indicator(s) are bullish while VERA’s TA Score has 5 bullish TA indicator(s).

  • CNTB’s TA Score: 4 bullish, 3 bearish.
  • VERA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both CNTB and VERA are a good buy in the short-term.

Price Growth

CNTB (@Biotechnology) experienced а +20.48% price change this week, while VERA (@Biotechnology) price change was +2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

VERA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.53B) has a higher market cap than CNTB($65M). CNTB YTD gains are higher at: -15.268 vs. VERA (-43.249). CNTB has higher annual earnings (EBITDA): -20.6M vs. VERA (-167.77M). VERA has more cash in the bank: 590M vs. CNTB (84M). CNTB has less debt than VERA: CNTB (940K) vs VERA (54.5M). CNTB has higher revenues than VERA: CNTB (26M) vs VERA (0).
CNTBVERACNTB / VERA
Capitalization65M1.53B4%
EBITDA-20.6M-167.77M12%
Gain YTD-15.268-43.24935%
P/E RatioN/AN/A-
Revenue26M0-
Total Cash84M590M14%
Total Debt940K54.5M2%
TECHNICAL ANALYSIS
Technical Analysis
CNTBVERA
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CNTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USLIX76.830.82
+1.08%
JHancock U.S. Global Leaders Growth I
SGAAX24.220.24
+1.00%
Virtus SGA Global Growth A
UPMMX29.430.21
+0.72%
Victory Precious Metals & Minerals Cl A
JETIX16.860.11
+0.66%
abrdn Focused Em Markets ex-China Instl
TRZRX15.59N/A
N/A
T. Rowe Price Real Assets Z

CNTB and

Correlation & Price change

A.I.dvisor tells us that CNTB and ABCZF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTB and ABCZF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTB
1D Price
Change %
CNTB100%
+8.27%
ABCZF - CNTB
28%
Poorly correlated
N/A
THAR - CNTB
25%
Poorly correlated
+2.20%
RANI - CNTB
25%
Poorly correlated
+0.68%
VERA - CNTB
23%
Poorly correlated
+1.48%
ALDX - CNTB
23%
Poorly correlated
+7.50%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
+1.48%
KYMR - VERA
54%
Loosely correlated
+0.58%
LYRA - VERA
54%
Loosely correlated
-3.33%
OPORF - VERA
50%
Loosely correlated
N/A
BPMC - VERA
47%
Loosely correlated
N/A
BNTX - VERA
40%
Loosely correlated
+1.61%
More